// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

An international perspective on the demographic and clinical features of exercise induced laryngeal obstruction

Emil S. Walsted - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Identifying patient suitability for lung volume reduction – estimation of gas trapping from spirometry

Amany Fathy Elbehairy - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Neural respiratory drive, respiratory mechanics and breathlessness in COPD patients with comorbid heart failure

Luis Estrada - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Congestive heart failure

N/A

Simplifying the measurement of neural respiratory drive index: parasternal electromyogram to measure respiratory rate

Grace McDowell - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Inter-observer reproducibility assessment of parasternal electromyogram(EMGpara analysis: a tale of two cities

Grace McDowell - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Reproducibility of Structured Light Plethysmography (SLP in different positions

Eyas Alhuthail - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Methacholine challenges: comparison of different tidal breathing challenge methods

James Dean - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

SK1211

A novel technique “slow spirometry” to estimate tidal volumes for use in AVAPS mode ventilation in children

Philip Lawrence - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Interim analysis of the effect of portable NIV (pNIV on thoracoabdominal volumes during intermittent exercise in COPD

Nikolaos Chynkiamis - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

For once, it’s not the heart! Exercise limitation in children from breathing pattern disorders post cardiac-surgery

Thomas Goddard - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An exploratory comparison between the ratio of 1:2 legged cycling peak workload and other physical performance measures

Tom Ward - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Cardiopulmonary response to stair climbing in patients with dysfunctional breathing

Karina Siewers - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Should the D1152H variant be included in cystic fibrosis newborn screening programmes?

Carwyn Dafydd - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Cystic fibrosis newborn screening for R117H in England

Carwyn Dafydd - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Impact of flash glucose monitoring system in cystic Fibrosis related diabetes

Safin Arafat Rahman - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Cystic Fibrosis

N/A

Expression and function of murine WFDC2 in the respiratory tract

Lynne Bingle - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients

Renate Kos - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Nasal high-flow therapy (NHFT during exercise in patients with cystic fibrosis (CF: a randomized crossover trial

Giulia Spoletini - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Cystic Fibrosis

N/A

European Cystic Fibrosis Society Clinical Trials Network (ECFS-CTN: structure and impact since 2009

Silke Van Koningsbruggen-Rietschel - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Spirometric phenotypes from early childhood to young adulthood – A CADSET (Chronic Airway Disease Early Stratification study

Erik Melén - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Copyright © 2026. QuantiNova All rights reserved